Yahoo Finance

BridgeBio Shares Positive Data from High Dose Cohort of Phase 1/2 CANaspire Study of Gene Therapy BBP-812 for Canavan Disease at ESGCT 2024

PALO ALTO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio ), a commercial-stage biopharmaceutical company focused on genetic diseases, presented positive ...
Yahoo Finance

BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1 Trial for SHP2 Inhibitor BBP-398 in Combination with Bristol Myers Squibb’s OPDIVO® (nivolumab)

PALO ALTO, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc., (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today ...
Nasdaq

SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts?

The Biotechnology sector is known to carry inherent risks as the stock price of a company in this sector can vary wildly based on the outcomes of clinical trials of drugs and regulatory interventions.
Business Wire

KKR Backs Energy Savings Solutions with Investment in Singapore’s BBP

SINGAPORE--(BUSINESS WIRE)--Leading global investment firm KKR today announced an investment in Barghest Building Performance (“BBP” or the “Company”), a Singapore-based provider of energy savings ...